The protein level of FABP3 was found to be significantly decreased in AD brains (p = 0.047, Figs. 4b,c) compared to cognitive health controls using Western blot and immunohistochemistry staining analysis of 20 postmortem brains (cf. Methods). Here, FABP3 is linked to Alzheimer disease.